Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics
International Journal of Nanomedicine · 2024
DOI: 10.2147/ijn.s448556 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2024. Verfasst von Hong-Yu Tao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Oncology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's…. Hauptthemen laut MEDLINE: Neoplasms, Telomere, Antineoplastic Agents, Telomerase. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Telomere is a protective structure located at the end of chromosomes of eukaryotes, involved in maintaining the integrity and stability of the genome. Telomeres play an essential role in cancer progression; accordingly, targeting telomere dynamics emerges as an effective approach for the development of cancer therapeutics. Targeting telomere dynamics may work through multifaceted molecular mechanisms; those include the activation of anti-telomerase immune responses, shortening of telomere lengths, induction of telomere dysfunction and constitution of telomerase-responsive drug release systems. In this review, we summarize a wide variety of telomere dynamics-targeted agents in preclinical studies and clinical trials, and reveal their promising therapeutic potential in cancer therapy. As shown, telomere dynamics-active agents are effective as anti-cancer chemotherapeutics and immunotherapeutics. Notably, these agents may display efficacy against cancer stem cells, reducing cancer stem levels. Furthermore, these agents can be integrated with the capability of tumor-specific drug delivery by the constitution of related nanoparticles, antibody drug conjugates and HSA-based drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Oncology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
ORCID-Profile: Ying Wang
Zitieren
APA
Tao, H. Y., Zhao, C. Y., Wang, Y., Sheng, W. J., & Zhen, Y. S. (2024). Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s448556
Vancouver
Tao HY, Zhao CY, Wang Y, Sheng WJ, Zhen YS. Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics. International Journal of Nanomedicine. 2024. doi:10.2147/ijn.s448556
BibTeX
@article{Tao2024,
author = {Tao, Hong-Yu and Zhao, Chun-Yan and Wang, Ying and Sheng, Wei-Jin and Zhen, Yong-Su},
title = {Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics},
journal = {International Journal of Nanomedicine},
year = {2024},
doi = {10.2147/ijn.s448556}
}
EUVIMED